Key Metrics
CiteScore 

2.2
H-Index 

15
SJR 

Q3Pharmacy

SNIP 

0.61
Recommended pre-submission checks
Powered by 

GaBI Journal Journal Specifications
| Overview | |
| Publisher | PRO PHARMA COMMUNICATIONS INT |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in GaBI Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in GaBI Journal
Biosimilars in oncology: beyond regulation—building confidence through evidence and dialogue
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Title not available
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Rising costs of biologicals: effective cost-containment does not please all stakeholders
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Australian biosimilar policies not delivering on intended outcomes: where to from here?
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Effective and safe handling of pre-filled syringe (PFS) for administration of biosimilar candidate AVT06 (aflibercept) in patients with chorioretinal vascular diseases
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Barriers to expanding biosimilars in oncological indications in Chile: A value-chain approach to understand visions and propose recommendations for improving value proposition
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Biosimilars in oncology: beyond regulation—building confidence through evidence and dialogue
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Title not available
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Rising costs of biologicals: effective cost-containment does not please all stakeholders
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Australian biosimilar policies not delivering on intended outcomes: where to from here?
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Effective and safe handling of pre-filled syringe (PFS) for administration of biosimilar candidate AVT06 (aflibercept) in patients with chorioretinal vascular diseases
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal
Barriers to expanding biosimilars in oncological indications in Chile: A value-chain approach to understand visions and propose recommendations for improving value proposition
- 15 Dec 2025
- Generics and Biosimilars Initiative Journal